Squarepoint Ops LLC Novo Nordisk A S Call Options Transaction History

Squarepoint Ops LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$119.07 - $145.42 $2.23 Million - $2.72 Million	18,700 Added 96.89%	38,000 $4.52 Million
Q2 2024 Aug 14, 2024	SELL	$122.71 - $146.91 $7.61 Million - $9.11 Million	-62,000 Reduced 76.26%	19,300 $2.75 Million
Q1 2024 May 15, 2024	SELL	$102.11 - $135.92 $183,798 - $244,655	-1,800 Reduced 2.17%	81,300 $10.4 Million
Q4 2023 Feb 14, 2024	BUY	$87.78 - $105.45 $7.29 Million - $8.76 Million	83,100 New	83,100 $8.6 Million
Q3 2022 Nov 14, 2022	BUY	$95.28 - $116.93 $1.14 Million - $1.4 Million	12,000 New	12,000 $1.2 Million

1,956

320M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $244B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.